Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery

Circulation Research

Volumn 85, Issue 12, 1999, Pages 1179-1185

  Mason, David P ^a   Kenagy, Richard D ^a   Hasenstab, David ^a   Bowen Pope, Daniel F ^b   Seifert, Ronald A ^b   Coats, Scott ^b   Hawkins, Suzanne M ^a   Clowes, Alexander W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Matrix metalloproteinase 9; Migration; Rat; Remodeling; Smooth muscle cell

Indexed keywords

COLLAGEN; GELATINASE B; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; MORPHOMETRICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RAT; TISSUE REPAIR; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 0033533994     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.12.1179     Document Type: Article

References (53)

1. Gibbons G, Dzau V. The emerging concept of vascular remodeling. N Engl J Med. 1994;330:1431-1438.
2. Faxon D, Coats W, Currier J. Remodeling of the coronary artery after vascular injury. Prog Cardiovasc Dis. 1997;40:129-140.
3. Schwartz S, deBlois D, O'Brien E. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
4. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb Al, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 1994;75:650-658.
5. Zempo N, Kenagy R, Au Y, Bendeck M, Clowes M, Reidy M, Clowes AW. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg. 1994;20:209-217.
6. Bendeck M, Zempo N, Clowes A, Galardy R, Reidy M. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994;75:539-545.
7. Woessner J. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
8. Brown D, Hibbs M, Kearney M, Loushin C, Isner J. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation. 1995;91:2125-2131.
9. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326: 310-318.
10. Carr S, Farb A, Pearce W, Virmani R, Yao J. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg. 1996;23:755-766.
11. McMillan W, Tamarina N, Cipollone M, Johnson D, Parker M, Pearce M. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation. 1997;96:2228-2232.
12. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG, Crow MT. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res. 1994;75:41-54.
13. Kenagy R, Hart C, Stetler-Stevenson W, Clowes A. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation. 1997;96:3555-3560.
14. Shockett P, Difilippantonio M, Hellman N, Schatz D. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci U S A. 1995;92:6522-6526.
15. Zempo N, Koyama N, Kenagy R, Lea H, Clowes A. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol. 1996;16:28-33.
16. Davies B, Brown P, East N, Crimmin M, Balkwill F. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 1993;53: 2087-2091.
17. Clowes M, Lynch C, Miller A, Osborne W, Clowes A. Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J Clin Invest. 1994;93: 644-651.
18. Clowes A, Reidy M, Clowes M. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
19. Geary R, Kohler T, Vergel S, Kirkman T, Clowes A. Time course of flow-induced smooth muscle cell proliferation and intimal thickening in endothelialized baboon vascular grafts. Circ Res. 1993;74:14-23.
20. Hardonk M, Harms G. The use of 5′-bromodeoxyuridine in the study of cell proliferation. Acta Histochem Suppl. 1990;39:99-108.
21. Dean D, Schwartz Z, Muniz O. Matrix vesicles are enriched in metalloproteinases that degrade proteoglycans. Calcif Tissue Int. 1992;50:342-349.
22. Oliver G, Leferson J, Stetler-Stevenson W, Kleiner D. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal Biochem. 1997;244: 161-166.
23. Chen L, Daum G, Forough R, Clowes M, Walter U, Clowes A. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Circ Res. 1998;82: 862-870.
24. r 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J Biol Chem. 1993; 268:19143-19151.
25. Sang Q, Stetler-Stevenson W, Liotta L, Byers S. Identification of type IV collagenase in rat testicular cell culture: influence of peritubular-sertoli cell interactions. Biol Reprod. 1990;43:957-964.
26. O'Connell J, Willenbrock F, Docherty J, Eaton D, Murphy G. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J Biol Chem. 1994;269:14967-14973.
27. Lyons JG, Birkedal-Hansen B, Moore WG, O'Grady RL, Birkedal-Hansen H. Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochemistry. 1991;30:1449-1456.
28. Webb K, Henney A, Anglin S, Humphries S, McEwan J. Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury. Arterioscler Thromb Vasc Biol. 1997;17:1837-1844.
29. Shah P. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation. 1997;96:2115-2117.
30. Schwartz S. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest. 1997;99:2814-2817.
31. Galis Z, Sukhova G; Lark M, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
32. Herron G, Unemori E, Wong M, Rapp J, Hibbs M, Stoney R. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms: involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb. 1991;11:1667-1677.
33. Dollery C, McEwan J, Henney A. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
34. Southgate K, Davies M, Booth R, Newby A. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J. 1992;288:93-99.
35. Kenagy R, Vergel S, Mattson E, Bendeck M, Reidy M, Clowes A. The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration. Arterioscler Thromb Vasc Biol. 1996;16:1373-1382.
36. Stuve O, Chabot S, Jung S, Williams G, Yong V. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. J Neuroimmunol 1997;80:38-46.
37. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson W, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 1997;277:225-228.
38. Laskin D, Kiumura T, Sakakibara S, Riley D, Berg R. Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils. J Leukoc Biol. 1986;39:255-286.
39. Senior R, Griffin G, Mecham R. Chemotactic activity of elastin-derived peptides. J Clin Invest. 1980;66:859-862.
40. Makowski G, Ramsby M. Binding of latent matrix metalloproteinase-9 to fibrin: activation via a plasmin-dependent pathway. Inflammation. 1998;22: 287-305.
41. Rocnik E, Chan B, Pickering J. Evidence for a role of collagen synthesis in arterial smooth muscle cell migration. J Clin Invest. 1998;101:1889-1898.
42. Allan J, Docherty A, Barker P, Huskisson N, Reynolds J, Murphy G. Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J. 1995;309:299-306.
43. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 1999;13:35-48.
44. Olson MW, Toth M, Gervasi DC, Sado Y, Ninomiya Y, Fridman R. High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV. J Biol Chem. 1998;273:10672-10681.
45. Brooks P, Stromblad S, Sanders L, Schalscha T, Aimes R, Stetler-Stevenson W, Quigley JP, Cheresh DA. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvB3. Cell. 1996;85:683-693.
46. Partridge C, Phillips P, Niedbala M, Jeffrey J. Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts. Am J Physiol. 1997;272:813-822.
47. Glagov S, Weisenberg E, Zarins C, Stankunavicius R, Kolettis G. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375.
48. Abbruzzese T, Guzman R, Martin R, Yee C, Zarins C, Dalman R. Matrix metalloproteinase inhibition limits arterial enlargement in a rodent arteriovenous fistula model. Surgery. 1998;124:328-335.
49. Tozzi C, Christiansen D, Poiani G, Riley D. Excess collagen in hypertensive pulmonary arteries decreases vascular distensibility. Am J Respir Crit Care Med. 1994;149:1317-1326.
50. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995;38:87-104.
51. Guzman R, Abe K, Zarins C. Flow-induced arterial enlargement is inhibited by suppression of nitric oxide synthase activity in vivo. Surgery. 1997;122: 273-280.
52. Sang Q. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 1998;8:171-177.
53. Mogford J, Davis G, Platts S, Meininger G. Vascular smooth muscle αvB3 integrin mediates arteriolar vasodilation in response to RGD peptides. Circ Res. 1996;79:821-826.